TP53 and Familial prostate cancer: Namely, Zhang et al. identified three metabolism-associated prostate cancer clusters that were characterized by significantly different outcomes in disease-free survival (DFS), clinical stage, stemness index, tumor microenvironment (including stromal and immune cells), presence of DNA mutation (TP53 and SPOP), copy number variation and microsatellite instability [51].